Enabling sutureless vascular bypass grafting with the exovascular sleeve anastomosis  by Chang, David W. et al.
524
The durability of vascular bypass grafting
remains the “gold standard” by which the newer
endovascular technologies are compared. Poor
patency rates hamper endoluminal approaches to
extensive occlusive vascular disease.1 Moreover, the
current endovascular repair of aortic aneurysms may
present a continuing risk of rupture from endoleaks
and is limited to patients with favorable anatomy.2
The chief disadvantage of traditional vascular bypass
grafting has been invasive operative exposure for the
procedure, which is required because of the difficul-
ty in performing a sutured vascular anastomosis in a
small confined space.
Nevertheless, progress continues to be made in
minimally invasive vascular bypass grafting. Small
retroperitoneal open incisions have been used to access
the abdominal aorta and have resulted in a shorter
period of ileus, diminished pulmonary complications,
and decreased postoperative length of stay.3
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Purpose: We describe a technique for end-to-end sleeve anastomosis that may enable min-
imally invasive bypass grafting and characterize the tensile strength, stenosis rate, dura-
bility, and healing of the anastomosis.
Method: An anastomotic device assembly consisting of a cable tie–type band with mobile
teeth elements is mounted on the outer surface of a polytetrafluoroethylene graft. The
graft is drawn over the artery resulting in a sleeve of vessel within the graft. As the band
is tightened over an intraluminal obturator, the independently mobile anchoring teeth
are driven through the graft into the artery. The tensile strength of the anastomosis was
compared with sutured anastomosis during in vitro studies using cadaveric human
femoral arteries. For in vivo studies on pigs and goats, we used a proximal exovascular
sleeve anastomosis along with a distal sutured aortic anastomosis. Survival animals were
studied by angiogram postoperatively and at the time of explantation.
Results: In vitro studies showed no difference in maximal tensile strength between
sutured and exovascular anastomoses (10.5 ± 2.7 lb vs 10.2 ± 3.0 lb, P = .83). However,
loss of continuous graft to artery interface occurred at lower loads in the sutured anas-
tomoses (6.5 ± 0.6 lb, P < .05). In total, all 24 pigs tested in nonsurvival or survival set-
tings sustained a successful and leakproof anastomosis. Of the 13 nonsurvival cases,
maximal epinephrine-induced hypertension sustained over 15 minutes (peak systolic
blood pressure > 210-250 mm Hg) was tolerated without leakage in a subgroup of five
animals (100%). All 11 survival pigs had no pseudoaneurysms or stenosis relative to
sutured control anastomoses at 6 week explantation (8.2 ± 1.25 mm vs 8.5 ± 1.6 mm,
P = .21). The three long-term survival goats had no pseudoaneurysm or stenosis after
40 weeks. Histologic examination confirmed healing of the aorta to graft with minimal
neointimal hyperplasia.
Conclusion: Exovascular sutureless anastomosis appears comparable to sutured anasto-
mosis in stenosis rate, healing, and durability, with some advantages in tensile strength
and rapidity of application. (J Vasc Surg 2000;32:524-30.)
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Dion et al4 reported the first laparoscopic-assisted
aortobifemoral bypass graft in 1993 and, subse-
quently, the first totally laparoscopic aortobifemoral
bypass graft.5 Although most procedures have been
performed for aortoiliac occlusive disease, Edoga6
recently reported a series of 22 totally laparoscopic
bypass grafts for abdominal aneurysms. These
advances have been characterized by increasing lev-
els of technical expertise attendant by a necessary
decrease in the number of surgeons capable of per-
forming the procedure. Of these skills, laparoscopic
vascular suturing is the most challenging and rate-
limiting step of the procedure.
Dion et al4 reported an end-to-end laparoscopic
aortic anastomosis performed in 50 minutes with a
73-minute cross-clamp time. Berens and Herde7
reported a 53-minute aortic cross-clamp time for an
end-to-side laparoscopic anastomosis. Three years
later, Barbera et al8 reported a series of 24 totally
laparoscopic vascular procedures for aortoiliac occlu-
sive disease without any lower mean cross-clamp
time for anastomosis. For minimally invasive vascu-
lar bypass grafting to advance from feasible to prac-
tical, a method to facilitate anastomosis is needed
that is reliable and easy to perform with limited
degrees of freedom.
We report the development of such a method
with a novel sutureless anastomotic device9 that
enables an end-to-end sleeve anastomosis to con-
ventional prosthetic grafts. These anastomoses are
studied in vitro by the use of cadaveric human
femoral arteries and in vivo by the use of nonsurvival
and survival animals with the aim to ultimately apply
sleeve anastomoses in minimally invasive settings.
Specifically addressed is a comparison of the exovas-
cular sleeve anastomosis with the conventional
sutured anastomosis in regard to tensile strength,
stenosis, leakage, and healing response.
MATERIALS AND METHODS
Device design. The exovascular anastomotic
device (Fig 1) is constructed with independently
mobile anchoring elements formed from 314-grade
stainless steel tubing (Small Parts, Inc, Miami Lakes,
Fla). For studies with diseased cadaveric human
femoral arteries, 2.2-mm teeth were used. For stud-
ies in healthy pig aorta, each element was fashioned
with a tissue-piercing component 1.5 mm in length.
Each anchoring element also consists of a tubular
body (T) 1.5 × 1 × 3 mm through which a nylon
cable tie (B) slides. The cable tie (Panduit Corp,
Springfield, Ill) has a unidirectional locking mecha-
nism (L) that allows fixation of the anchoring ele-
ments once they have been embedded by the con-
stricting band. Each anchoring element is separated
by a spacing element made of thermal plastic wire
insulating material (S) 1.5 × 1 × 3 mm in dimension.
These elements ensure tissue penetration at precise
intervals and conform to the space between anchor-
ing elements.
The current design using a commercially avail-
able cable tie prevents placement of an anchoring
element at the locking head of the device. Fig 2
shows the device and graft assembly with this area of
anastomotic weakness. There is a small space
between the graft and the device locking mechanism
(Fig 1, L) that decreases the reliability of the seal.
Initially, this limitation was overcome by placing sev-
eral sutures at the locking head to mimic a custom-
designed band with an anchoring element at this
site. Two adjacent bands were used in subsequent
anastomoses and were positioned so that the teeth of
Fig 1. Schematic representation of the exovascular sleeve anastomosis. The assembly consists of a cable
tie band (B) with independently mobile teeth elements (T) and spacing elements (S) premounted on a
PTFE graft (G). The graft is drawn over the artery (A) resulting in a sleeve (Sl) of vessel within the graft.
As the band is tightened by a cable tie applicator over an intraluminal obturator, the teeth are anchored
into the artery. The unidirectional locking mechanism (L) of the cable tie prevents the band from loos-
ening.
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one band covered the space of the other band, ren-
dering a completely sutureless anastomosis.
Description of in vitro technique. Anastomoses
between cadaveric human femoral arteries and 8-
mm polytetrafluoroethylene (PTFE) grafts were
made with continuous running 5.0 Prolene suture
or with the exovascular anastomotic device. The
anastomoses were tested on a vascular simulating
device previously described by our laboratory.10
Mean pressure was titrated by increasing the gas in
the pressurized silicone tubing while a pulsatile
waveform was generated by a bellows pump. We
were therefore able to achieve supraphysiologic pul-
satile pressures greater that 300 mm Hg in a water-
filled closed circuit. The anastomoses were then
tested for tensile strength with an electromechani-
cal-coupled tension meter.
Description of in vivo technique. In all exovas-
cular sleeve anastomoses (in vitro and in vivo), the
device was premounted on an 8-mm PTFE graft. An
obturator was inserted within to support the artery
while the teeth anchored in the vessel without pro-
truding into the lumen. Approximately 1 cm of ves-
sel was used as a sleeve in the anastomosis to accom-
modate two anastomotic bands placed adjacently. A
shorter sleeve was not tested in this series of experi-
ments given the current constraints of design.
In the in vivo studies, access to the infrarenal
aorta was obtained through a retroperitoneal
approach with a muscle-splitting incision midway
between the iliac crest and inferior most rib of the
animal. Vascular control of the infrarenal aorta was
obtained with tourniquet clamps. Before cross-
clamping, 2 mg/kg of heparin sulfate was adminis-
tered intravenously. The aorta was transected, and
two stay sutures were placed 180 degrees apart. No
stay sutures were required to apply the device in the
more rigid and diseased human vessels. The graft-
device assembly was mounted on a metal obturator
that was placed in the lumen of the artery. The graft
was guided down the tapered obturator to overlap a
sleeve of artery. The proximal tourniquet clamp was
then released, and the obturator was inserted further
to support the vessel during firing of the device.
Each device was embedded with a cable tie applica-
tor (Panduit Corp) set at 50-lb tension. A conven-
tional sutured distal anastomosis was performed
with continuous running 5.0-Prolene suture (US
Surgical Corp, Norwalk, Conn).
Twenty-eight animals were studied in vivo,
including eleven 6-week survival pigs and three 40-
week survival goats. Goats were used instead of pigs
for the long-term survival studies because of their
more stable size. A fourth goat was humanely killed
1 week after suboptimal implantation of the device
led to an asymptomatic thrombosis of the graft.
Angiography. An angiogram was performed
with a 5-in 18-gauge angiocatheter tip placed oper-
atively above the proximal anastomosis. Twenty
cubic centimeters of renograffin was injected, and
cut film images were obtained. Because the animals
were heparinized, the puncture site was repaired
with a single 5.0 Prolene suture during the initial
angiogram. The incision was closed with 3.0 Vicryl
sutures (US Surgical Corp), and the animal was
extubated.
Histology. Specimens were immediately fixed in
10% phosphate-buffered formalin after explantation.
After 2 weeks, the device bands were carefully
removed. Thick 6-µm longitudinal sections were
made after embedding the specimens in paraffin to
minimize shear artifact at the graft-artery interface.
Hematoxylin-eosin and Masson stains were per-
formed on the sections.
Statistical analysis. Statistical analysis was per-
Fig 2. A model of the exovascular anastomotic device
demonstrating anchoring of the teeth (seen best at the 5-
o’clock position) through a backlit cross-section of poly-
ethylene tubing representing an artery. As shown, the
device has been applied to Dacron grafts as well as PTFE
grafts.
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formed with SAS software Version 6.01 (SAS
Institute, Cary, NC) on a Pentium PC microcom-
puter (Compaq Corp, Houston, Tex). Data were
expressed as mean ± SD. Differences between each
survival animal with case and control anastomoses
were analyzed by a paired t test while differences
between the sutured and sutureless anastomosis
groups with human femoral arteries were analyzed
with the t test for independent samples. A P value
less than .05 was chosen as the level of significance.
RESULTS
In vitro studies with cadaveric human femoral
arteries. The maximal sustained load was 10.5 ± 2.7
lb in the exovascular sleeve anastomoses (n = 8) and
10.2 ± 3 lb (n = 8) in conventional sutured anasto-
moses (Fig 3). The exovascular sleeve anastomosis
exhibited no separation of artery from the graft until
maximal breakpoint load. Although there was no sig-
nificant difference in maximal tensile strength
between the two groups (P = .84), separation of the
artery-graft interface occurred at significantly lower
loads in the end-to-end sutured anastomoses (6.5 ±.6
lb, P < .05). The anastomoses tolerated systolic pres-
sures in excess of 300 mm Hg without leak.
Nonsurvival studies. Successful application of
the device without leak was achieved in all 13 non-
survival pigs. All anastomotic bands were applied in
less than 15 seconds. A subgroup of five animals in
which completely sutureless double devices at the
proximal anastomosis were used was given an infu-
sion of epinephrine (15-25 mg total dose). The
anastomoses were resistant to leakage during maxi-
mal supraphysiologic epinephrine–induced hyper-
tension sustained over 15 minutes. The peak systolic
blood pressure (210-250 mm Hg) was lower than
that in the in vitro studies as a result of the relative-
ly more compliant pig vessels.
Intermediate-term survival studies. All 11 sur-
vival animals, including six with double devices at
the proximal anastomosis, had no pseudoaneurysms
at 6 to 8 weeks. The mean anastomosis time was 5
minutes. Intraoperative aortogram (Fig 4) just
before explantation demonstrated no significant nar-
rowing (P = .21) of the exovascular anastomosis (8.2
± 1.25 mm) relative to the control sutured anasto-
mosis (8.5 ± 1.60 mm). One animal had a large lym-
phocele associated with proliferative changes at both
the exovascular and control anastomosis. This ani-
mal had a 55% stenosis at the exovascular anastomo-
sis and a 66% stenosis at the sutured control anasto-
mosis. At explantation two of the grafts had small
foci (< 2 × 2 × 1 mm) of organized clot in the
midgraft region but not in the anastomotic region.
Long-term survival studies. All three 40-kg male
goats followed up for 40 weeks survived without
pseudoaneurysm or stenosis. At explantation, vessel
wall thickness at the exovascular sleeve anastomosis
was comparable to the sutured control anastomosis
(Fig 5). A fourth goat was found to have a 35% steno-
sis on postoperative angiogram because of suboptimal
firing of the anastomotic device. The aortic graft
thrombosed asymptomatically within 1 week. The ani-
Fig 4. Intraoperative angiogram of a pig aorta just before
explantation of device shows no stenosis of the sutureless
anastomosis relative to the graft, the distal sutured anasto-
mosis, or the obturator used to apply the device (bottom
left). After a 2-month survival course, there is an increased
diameter of the native proximal and distal aorta as the ani-
mal grows from 35 to 70 kg.
Fig 3. Separation of the interface between graft and artery
(functional load) then complete uncoupling of the anasto-
mosis (maximum load) are reported in anastomoses with
the Exovascular Anastomotic Device and sutures.
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mal was humanely killed because the long-term behav-
ior of the anastomosis could no longer be evaluated.
Histology. Longitudinal sections of the explant-
ed aorta and graft were stained with hematoxylin
and eosin after removal of the device at 40 weeks
(Fig 6, A). A fibrous capsule enveloped the device
and was limited to anastomotic region. There was
incorporation of the graft with fibroblast ingrowth
Fig 5. Longitudinal section of explanted goat aorta at 40 weeks with exovascular sleeve anastomosis on
the left and sutured anastomosis on right. The slight buckling of the aorta at the exovascular anastomo-
sis is an artifact of formalin fixation in an unpressurized environment (and not seen on angiogram).
Fig 6. A, Photomicrograph of goat aorta at 40 weeks with a longitudinal section of a portion of the exo-
vascular sleeve anastomosis on the right. The location of the anastomotic band is at the lower right (b);
×30, hematoxylin and eosin. B, Magnified view of the sleeve anastomosis showing incorporation of the
PTFE graft with cellular elements (arrow). There is minimal neointimal hyperplasia in the anastomotic
sleeve; ×150, hematoxylin and eosin. C, The internal elastic lamina and elastin within the aortic wall (red
staining) are preserved as well as endothelial cells (arrow); ×300, Masson.
from the intersuscepted aortic segment into the
sleeve anastomosis (Fig 6, B). An endothelial cell lin-
ing was observed in the sleeve segment. There was
minimal neointimal hyperplasia in the sleeve anasto-
mosis at 40 weeks. Normal aortic wall architecture
was preserved including endothelial cell lined intima
and elastin layers in the media (Fig 6, C).
DISCUSSION
While successfully embraced in general surgery,
sutureless mechanical anastomosis has yet to find its
place in vascular surgery. Initial experience focused
on healthy conduits whose walls are more akin to
those found in the pliable gastrointestinal tract. In
1956, in one of the first reports of sutureless anasto-
mosis, an anastomosis ring was used; protrusions had
been extended radially and outwardly for impaling
the vessel ends.11 In another approach two anasto-
mosis rings were used that kept the everted intima of
the vessels in apposition.12 Significant manipulation
or eversion of the vessel wall is required to produce a
reliable seal. These devices illustrate the fundamental
flaw of many subsequent attempts that were success-
ful in normal but not diseased vessels. Other devices,
which include the endovascular stent grafts, have
relied on an intraluminal component to anchor the
anastomosis, but the durability of the fixation
remains uncertain.
The defining characteristics of the technique under
study are an exovascular device, an exovascular graft,
and an anastomotic sleeve junction. Components of
the anastomotic design confer advantages that are out-
lined below.
Exovascular device. Migration and endoleaks of
self-expanding and balloon-expandable endoluminal
stents suggest a less securely anchored anastomosis
with these devices compared with conventional
sutured anastomosis. The exovascular position of the
device enables the graft to be anchored in relatively
healthy adventitia. The comparable tensile strength
between exovascular and sutured anastomoses is
consistent with the understanding that the adventi-
tia is the strength layer of an anastomosis. Our in
vitro results suggest that exovascular anastomosis is
comparable in anastomotic tensile strength to the
gold standard sutured anastomosis. In addition,
unlike other attempts at sutureless anastomosis, dis-
eased and calcified vessels can be anastomosed with-
out any distortion because of the exovascular 
position of the device. Most important, we observed
that the exovascular device markedly decreased the
time and effort needed to perform an anastomosis 
(< 15 seconds) and embedded more quickly and 
easily than sutures in some of the more calcified
human femoral arteries.
A more sophisticated embodiment may include
the facility to fully penetrate the artery wall and bend
the distal tip of anchoring elements like a stapler.
This may further secure the anastomosis when the
device is used for smaller or thin-walled vessels (eg,
a vein-to-vein anastomosis to extend a saphenous
vein bypass graft). Subsequent iterations of this
device can be incorporated as a component of a sin-
gle graft/anastomotic device assembly. A modified
angioplasty balloon may also be used instead of a
rigid obturator.
Exovascular graft. The exovascular orientation of
the graft prevents narrowing of the conduit and, in
fact, permits the application of a graft diameter several
millimeters larger than the diseased native vessel.
Increased graft diameter of this magnitude has been
shown to improve patency of femoropopliteal grafts.13
However, the exovascular position of the graft results
in some exposed media and adventitia at the transect-
ed vessel end within the graft. We have shown through
in vivo studies that this is well tolerated in a proximal
anastomosis. The success of this configuration in a 
distal anastomosis is unknown and will need to be
investigated.
The use of the exovascular sleeve anastomosis is
demonstrated in its potential to facilitate the proxi-
mal intra-abdominal aortic anastomosis in a mini-
mally invasive fashion. In bypass grafting for aortoil-
iac occlusive disease, it is likely to be followed by an
end-to-side distal anastomosis. At this peripheral
site, a conventional open anastomosis carries less
morbidity and permits back perfusion to bypassed
arterial segments. Similarly, a conventional distal
anastomosis can be used in bypass grafts for
aneurysms after stapling of the distal end of the
aneurysm.4
An aortic anastomosis model was used to test the
concept of an exovascular anastomosis. This suture-
less anastomosis may also find application for differ-
ent anatomical sites. For example, proximal anasto-
mosis to the superficial femoral artery of a
femoropopliteal or distal bypass graft can be per-
formed. Also, a prosthetic interposition graft may
rapidly be anastomosed in the setting of arterial trau-
ma. The exovascular anastomosis may also be used
to perform anastomoses on different types of vessels.
For example, a vein-to-vein anastomosis to splice
short saphenous vein segments for distal bypass graft
or a prosthetic-to-vein anastomosis in dialysis access
surgery may be performed.
Sleeve anastomosis. The sleeve anastomosis
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increases the surface contact area between the vessel
and graft, making it more tolerant of operator error
than either a sutured or sutureless end-to-end anas-
tomosis. This increased contact area is advantageous
in obtaining an immediate seal and requires less pre-
cision in the performance of an anastomosis. The
sleeve anastomosis also allows a greater zone of anas-
tomotic healing and incorporation of the graft.
There is continued apposition of graft to artery even
if there is some displacement at the sleeve anasto-
mosis with increasing tension. We therefore hypoth-
esize that the sleeve anastomosis might have a lower
incidence of anastomotic pseudoaneurysms than
sutured end-to-end anastomosis. This is suggested
in our in vitro tension studies that show separation
of graft from the artery at lower loads in sutured
anastomoses. In our series of survival animals no
anastomotic pseudoaneurysm or stenosis developed
over the survival course using this technique.
CONCLUSION
The exovascular sleeve anastomosis appears to be
a feasible alternative to endovascular or conventional
sutured anastomosis. In vitro and survival studies
suggest that this anastomosis is as strong and durable
as conventional sutured anastomosis with follow-up
of 40 weeks with some advantage in resisting leakage
under tension. The exovascular device has a fault tol-
erant design and rapid anastomotic application.
Although they are not the focus of the current stud-
ies, these characteristics may allow it to expedite min-
imally invasive vascular bypass graft anastomosis.
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